Introduction: Robotic hysterectomy may offer advantages for complex cases over the conventional laparoscopic approach.
INTRODUCTION
In the US, laparoscopic hysterectomies now comprise most hysterectomies. [1] [2] [3] [4] In the past decade, uptake of the robotic platform has been rapid. Although robotic hysterectomy offers ergonomic advantages over conventional laparoscopy, the differences in clinical outcomes appear to be marginal with substantially higher cost. 1, [5] [6] [7] [8] However, the robot may offer advantages for complex patients. 9 Studies comparing outcomes of robotic and conventional laparoscopic hysterectomy for benign conditions have been limited. Past studies have not fully adjusted for surgeon factors, were limited by small numbers of surgeons, [10] [11] [12] focused on low-volume surgeons, [13] [14] [15] [16] and did not assess complex patients. 17, 18 We conducted a retrospective, longitudinal, cohort study in a community-based setting to compare outcomes after robotic vs conventional laparoscopic hysterectomy. The analysis stratified complex and noncomplex patients and accounted for surgeon factors.
METHODS

Setting
Kaiser Permanente Northern California (KPNC) is an integrated health care system that provides capitated services and uses an Epic-based electronic medical record (Epic Systems, Verona, WI). Hysterectomies are performed at 23 hospitals, and more than 90% of these surgical procedures are minimally invasive. Four hospitals have a robotic platform. An e-consult system implemented in 2013 enables referral of patients with benign gynecologic disease for robotic hysterectomy when the surgery is expected to take longer than 180 minutes, or for patients defined as complex, that is, with a high body mass index (particularly ≥ 45 kg/m 2 ), suspected moderate to severe endometriosis or pelvic adhesions, large uterus (≥ 700 g), wide width of lower uterine segment, or large posterior myoma.
Study Population
The retrospective cohort study included women aged 20 to 69 years at hysterectomy performed from January 1, 2011, to September 30, 2015, who had 1 year or more enrollment in KPNC before surgery. We excluded women undergoing hysterectomy with concomitant procedures for treatment of incontinence or uterine prolapse; women with a discharge diagnosis of cancer within 30 days before hysterectomy; and women who underwent an unlisted laparoscopic procedure on the uterus, a radical hysterectomy, or a hysterectomy because of malignancy (see Supplemental Table 1 a ). We also excluded women who were pregnant 30 days or less before hysterectomy or had concurrent procedures for maternity care and delivery.
Consistent with the e-consult system implemented in 2013, we defined complex patients as having a body mass index of 45 kg/m 2 or greater, uterine weight of 700 g or more, or past diagnosis of adhesions. We did not have information on the severity of endometriosis, the width of the lower uterine segment, or the location of the myoma.
Study outcomes were obtained from the electronic medical record and operative report and included blood loss; length of stay; 90-day readmission, reoperation, and operative complications, including gastrointestinal tract, urinary tract, vascular, renal-electrolyte, and nonoperative site infections; and other surgical and medical complications. Operational definitions are provided in Supplemental Table 1 . a We analyzed operative time (minutes from incision start to closure). For robotic hysterectomy, the operative time includes manipulator placement, docking, and the surgery itself, including morcellation.
Patient-level covariates included age, self-reported race/ethnicity, and body mass index, obtained from inpatient or outpatient encounters during the year before the hysterectomy. Uterine weight was ascertained using natural language processing of the pathology report. History of gynecologic diagnoses and procedures and the Charlson Comorbidity Index were obtained using diagnostic and procedure codes recorded during the year before hysterectomy (see Supplemental Table 1 a ). 19 The indication for hysterectomy was determined using inpatient diagnoses recorded on the day of hysterectomy (see Supplemental Table 1 a ), using the following hierarchy: Leiomyoma first, followed by uterine bleeding, endometriosis, pelvic pain, hyperplasia, and finally, other.
Surgeon-level covariates included age, race, sex, year at start of practice with KPNC, number of years between the end of training and the start of practice, and past hysterectomy volume (time-dependent variable). Surgeons who performed laparoscopic hysterectomies for cancer removal were included if they had performed at least 1 hysterectomy with an indication for benign disease. Surgeons who performed at least 1 robotic hysterectomy during the study period were classified as "robotic surgeons"; all other laparoscopic surgeons were classified as "conventional surgeons."
Statistical Analysis
We compared robotic and conventional hysterectomy separately for complex and noncomplex patients. For the analysis of blood loss, we fit mixed-effects regression models (multilevel models) with adjustment for patient and surgeon characteristics. Patient characteristics included year of surgery; age; race/ethnicity; body mass index; uterine weight; past diagnosis of endometriosis, adhesions, or uterine bleeding; and past genitourinary or abdominal surgery or cesarean delivery. As described in the following paragraph, for patients undergoing conventional surgery, we accounted for the surgeon's past volume of conventional hysterectomies, and for patients undergoing robotic surgery, we accounted for the surgeon's past volume of robotic hysterectomies. In addition, we adjusted for the surgeon and the hospital using random covariates. The random covariate for surgeon allowed each surgeon to have his/her own mean blood loss, separate from his/her past surgical volume.
The surgeon's past volumes for conventional and robotic surgery were computed as time-varying covariates that were updated with each new patient. For example, a robotic surgeon's volume after his/ her first robotic hysterectomy at KPNC was counted as 1, whereas his/her volume after the 75th robotic hysterectomy was counted as 75. We began these counts on the later of either 2005, when the electronic medical record was implemented, or the day the surgeon joined the Health Plan. The calculation of route-specific volume included cancer cases, even though cancer cases were excluded from the study population. Cut points to define volume as low, medium, or high were determined by analyzing the association of surgical volume with operative time, a measure of surgeon learning. These analyses, performed separately for conventional and robotic cases, used generalized additive mixed models to account for clustering of patients within surgeons and clustering of surgeons within hospitals, spline-smoothing random effects, and patient-level factors. 20 We defined cut points for low, medium, and high volume on the basis of the shape of the splines separately for conventional and robotic surgeons.
Length of stay longer than 2 days, and readmission, reoperation, and complications through 90 days were analyzed as dichotomous outcomes. We used the Kaplan-Meier method to compute incidence. Follow-up started on the date of surgery and ended on the date of outcome, death, disenrollment from the Health Plan, the 90th day after the surgery, or the end of the study on September 30, 2015. Because these outcomes are relatively rare and sample size was limited, these analyses did not account for surgeon factors or hospital. All analyses were performed using statistical software (SAS 9.3, SAS Institute Inc, Cary, NC; and R 3.2.2, The R Foundation). The Kaiser Permanente institutional review board approved this project (CN-14-1832-H) on April 15, 2014.
RESULTS
The study included 7345 patients who met inclusion criteria, of which 6785 (92%) underwent conventional laparoscopic and 560 (8%) underwent robotic hysterectomies ( Figure 1 ). Overall, 1836 patients (25%) met the criteria for being a complex patient, including 236 (42% of 560) undergoing robotic a Complex was defined as any patient with at least 1 of the following conditions within 1 year before surgery: Body mass index ≥ 45 kg/m 2 , uterine weight ≥ 700 g, or past diagnosis of adhesions. b p < 0.0001. c p < 0.01. d p < 0.05. e Information on uterine weight was missing for 16 patients who underwent robotic hysterectomy and 353 patients who underwent conventional laparoscopic hysterectomy. f For those with multiple indications, we assigned a single indication using the following hierarchy: Leiomyoma first, followed by uterine bleeding, endometriosis, pelvic pain, hyperplasia, and finally, other. g Other indication includes noninflammatory disease, pelvic inflammatory disease, uterine disorder NOS, other disorders of the female genital tract, prophylactic ovary/gland removal, and genetic susceptibility to malignant tumor. Other past diagnoses include uterine NOS, fistula, hematometra, synechiae, and malposition. NOS = not otherwise specified; PID = pelvic inflammatory disease. (Table 1) . Robotic hysterectomies were performed more commonly in more recent years (p < 0.0001) and among women with complex disease (p < 0.0001; Table 1 ). Among complex patients, conventional and robotic cases were similar in frequency with respect to age and race/ethnicity. Robotic surgical patients were more likely to have 2 or more Charlson comorbidities (p < 0.0001) and body mass index greater than or equal to 45 kg/m 2 (p < 0.0001). More robotic cases involved a history of endometriosis (p < 0.01), pelvic inflammatory disease (p < 0.05), pelvic disease not further specified (p < 0.05), hyperplasia (p < 0.0001), and genitourinary disease (p < 0.05). Conventional cases were more likely to have a past abdominal procedure (p < 0.0001). Among noncomplex patients, those undergoing robotic surgery were older (p < 0.0001), were disproportionately nonwhite (p < 0.01), had greater body mass index (p < 0.05), were more likely to have an indication of hyperplasia (p < 0.0001), and had more complicated histories with respect to past diagnoses. The study included 376 surgeons, of which 31 had performed at least 1 robotic hysterectomy during the study period ("robotic surgeons") and 345 had performed only conventional laparoscopic hysterectomy ("conventional surgeons"; Table 2 ). Robotic and conventional surgeons were similar in age, sex, race/ethnicity, year at start of practice with KPNC, and number of years between the end of training and start of practice with KPNC. By the end of the study period, the conventional surgeons performed an average total of 52 hysterectomy cases (range = 1-530 cases).
Characteristic
In contrast, the robotic surgeons performed an average total of 94 robotic cases (range = 1-373 cases) and an average of 251 conventional cases (range = 1-701 cases). Eleven of the robotic surgeons (35%) and 2 of the conventional surgeons (1%) were gynecologic oncologists, and we therefore performed sensitivity analyses excluding the gynecologic oncologists.
Operative time was used as an outcome in an analysis that used splines to define cut points for the surgeon's time-varying volume (low, medium, high). These results are shown in Figure 2 
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Outcomes of Robotic Hysterectomy for Treatment of Benign Conditions: Influence of Patient Complexity their first robotic surgery, with the average number of conventional procedures before the first robotic surgery being 232. The 2 intercepts are similar, suggesting that a surgeon performing his/her first robotic case had about the same operative time as a surgeon performing his/her first conventional case. Operative time decreased as volume increased for both groups, but the rate of decrease was greater for robotic surgeons, indicating a more rapid learning curve together with a lower floor, and this difference was statistically significant (p = 0.01). For the robotic surgeons, we observed a modest rise and fall of operative time between 100 and 300 surgeries; this curve was based on relatively small numbers, and the wide confidence band around the curve shows that the true trend may be anywhere in that band, and may actually be flat between 100 and 300 surgeries. On the basis of these splines, we defined low volume as less than or equal to 49, medium as 50 to 199, and high as 200 or more cases for conventional surgeons. For the robotic surgeons, we defined low volume as 24 or fewer cases, medium as 25 to 74, and high as 75 cases or more.
The average operative time was 152 minutes (95% confidence interval [CI] = 146-157 minutes) for robotic hysterectomy and 157 minutes (CI = 155-158 minutes) for conventional laparoscopic hysterectomy, a significant difference (p < 0.0001). In operative time, complex patients averaged 190 minutes (CI = 187-194 minutes) and noncomplex cases averaged 144 minutes (CI = 141-147 minutes, p < 0.0001). The adjusted association of mean operative time with patient characteristics is shown in Table 3 , where -7 minutes, for example, indicates that robotic hysterectomy was faster by 7 minutes. Patient factors that contributed to longer operative times included body mass, uterine weight, past diagnosis of adhesions, and history of a past genitourinary procedure (all p < 0.0001). A later year of surgery was associated with shorter operative time.
Differences in operative times in relation to surgical approach, patient complexity, and surgeon volume are shown in Table 4 . For both robotic and conventional surgeons, average operative times decreased with increasing level of volume. For complex patients, high-volume conventional surgeons were 28 minutes faster (CI = 15-42 minutes) than low-volume conventional surgeons, and high-volume robotic surgeons were 52 minutes faster (CI = 31-75 minutes) than low-volume robotic surgeons. After controlling for the surgeon's volume, patient characteristics, and hospital, high-volume surgeons treating complex patients with robotic hysterectomy were 21 minutes (CI = 0-43 minutes, p < 0.05) faster than surgeons using conventional hysterectomy. For noncomplex patients, highvolume conventional surgeons were 18 minutes faster (CI = 11-25 minutes) than low-volume conventional surgeons, high-volume robotic surgeons were 25 minutes faster (CI = 11-39 minutes) than low-volume robotic surgeons, and high-volume robotic surgeons were 8 minutes faster (CI = 3 minutes slower to 19 minutes faster) than high-volume conventional surgeons.
Unadjusted blood loss averaged 100 mL for complex patients and 90 mL for noncomplex patients (Figure 3 ). In complex patients who underwent conventional surgery, the odds of blood loss of 51 mL or greater was not related to the surgeon's volume ( Table 5 ). In contrast, in complex patients who underwent robotic surgery and in noncomplex patients who received conventional or robotic surgery, the odds ratio for blood loss of 51 mL or greater declined sharply with increasing volume. Overall, robotic surgery was associated with lower blood loss for both complex patient (adjusted odds ratio = 0.20; CI = 0.08-0.53) and noncomplex patients (adjusted odds ratio 0.12; CI = 0.06-0.27).
For both complex and noncomplex patients, robotic cases and conventional cases were similar in average length of stay and risks of readmission by 90 days, reoperation, and most complications (Supplemental Table 2 a ). Among noncomplex cases, robotic surgery was associated with complications of the urinary tract (5.2% vs 3.2%, p = 0.04). The analysis assessed injury to pelvic organs (n = 24, 9% of urinary complications), peritonitis (n = 0, 0%), stricture or kinking of the ureter (n = 2, 0.8%), urinary tract infection (n = 204, 77%), and urinary complications not otherwise specified (n = 35, 13%). The frequency of urinary complications, Table 3 , first footnote. The multilevel regression model also adjusted for all patient-level variables as shown in Table 2 , using the same coding shown in Table 2 , and it was adjusted for surgeon and hospital identifiers using random covariates. c Complex was defined as body mass index ≥ 45 kg/m 2 , uterine weight ≥ 700 g, or past diagnosis of adhesions. The analysis excluded 369 patients with missing information on uterine weight. CI = confidence interval. composed of mostly urinary tract infections, was 8.5% in robotic surgeries by low-volume surgeons and 3% to 4% in all other groups (p = 0.004). We observed no other significant differences in risk of complications between conventional and robotic cases. However, among complex patients, the frequency of urinary tract complications was 9.2% in low-volume robotic surgeons and 2% to 4% in other surgeons, and this was of borderline significance (p = 0.13). Sensitivity analyses excluding patients treated by gynecologic oncologists affected the results shown in Tables 1 to 5 only negligibly.
DISCUSSION
In a longitudinal study of robotic and conventional laparoscopy, we observed an association for complex patients of faster operative time for high-volume robotic surgeons. We also observed an association of lower risk of blood loss with robotic surgery for complex and noncomplex patients, and an association of robotic surgery with the risk of a urinary tract complication in noncomplex patients. For both complex and noncomplex patients, the longest operative times were associated with low-volume surgeons.
a Complex defined as body mass index ≥ 45, uterine weight ≥ 700 g, or past diagnosis or adhesions. b Per year is the change in odds for each year, ie, a decrease in the odds by 0.92 for surgery year and an increase in odds by 1.02 for age. Thus, the OR for a 5-year change in age is 5^1.02 = 1.10. c The analysis excluded 369 patients with missing information on uterine weight and 46 patients with missing information on blood loss and included 536 robotic cases and 6394 conventional cases. Each of the 2 multilevel models (complex, noncomplex) was adjusted for key patient characteristics including year of surgery; age; race/ethnicity; body mass index; uterine weight; past diagnosis of endometriosis, adhesions, or uterine bleeding; and past genitourinary or abdominal surgery, or cesarean delivery. In addition, we adjusted for surgeon and hospital by using random covariates. The random covariates account for the natural ability of the surgeon, separate from their volume, and for differences across hospitals. d We coded each surgeon's volume separately for robotic and conventional hysterectomy using information from 2005 or the surgeon's date of joining Kaiser Permanente (whichever was later) to each patient's index date. Thus, it was a time-varying covariate. For robotic surgeons, low was defined as ≤ 24, medium-volume as 25-74, and high-volume as ≥ 75 cases before the current patient. For conventional surgeons, low was defined as ≤ 49, medium-volume as 50-199, and high-volume as ≥ 200 cases before the current patient. NOS = not otherwise specified; OR = odds ratio; PID = pelvic inflammatory disease. Notwithstanding our finding for urinary tract complication, our results for complications are broadly consistent with a Cochrane review that found little difference between surgical approaches (relative risk = 1.23, 95% CI = 0.44 to 3.46). 6 Only 1 past report of New York discharges clearly documented how International Classification of Diseases, Ninth Revision, codes were used to define outcomes, and we aligned our definitions with that approach. 21 Our outcome definitions were also consistent with past studies of complications after conventional and vaginal laparoscopic hysterectomy. 22, 23 Our study differs from past observational studies in that we ascertained the patient's complexity using clinical information. Other large observational studies used claims captured in the National Inpatient Sample, 7,24 statewide databases, 5,21-23 and large insurance databases. 1 These studies did not have information on the patient's complexity and did not detail their definitions, making comparisons difficult. Several smaller studies set in 1 or 2 institutions used chart reviews to assess complications. [25] [26] [27] [28] The large number of patients and transparent definitions we used for complications are strengths of the present study.
Our results for the robotic approach are consistent with those of a Dutch study that found robotic surgery was 18 minutes faster than conventional surgery after adjusting for the patient's body mass index (2 min/unit > 20 kg/m 2 , p < 0.001), uterine weight (0.2 min/g > 80 g, p < 0.001), and history of abdominal surgery (history vs no history, 12 minutes, p = 0.02). 29 The study included 171 robotic hysterectomies performed during 2002 to 2014 for benign (42%) and malignant (58%) indications and differed from ours in including oncology cases and in not considering surgeon factors. A second study used a statewide Michigan database to analyze 1338 robotic hysterectomies performed for benign indications. 5 They were compared with conventional laparoscopic and vaginal hysterectomies after propensity score matching on 10 patient-level variables and 2 hospital-level variables. Surgical time was longer for robotic surgery (compared with nonrobotic: 2.3 vs 2.0 hours, p < 0.001). However, the study did not have information on patient complexity or the surgeon's volume. A hospital-based study gave evidence that robotic surgery can be more rapid than conventional laparoscopic surgery once a surgeon has become proficient, after approximately 75 procedures. 29 However, the interaction of robotic surgery with surgeon volume has not been assessed in other reports, to our knowledge. Future studies should consider this interaction when one is deciding how to analyze robotic and conventional surgeries.
The present study could not account for several important factors. First, robotic surgeons had performed an average of 232 conventional surgeries before performing their first robotic surgery. This represents intensive training that alone may have improved their operative time. Second, the study included only 31 robotic surgeons, and our experience may not generalize entirely to other settings, although many patients in our study were treated by low-volume surgeons. Third, although we carefully examined and adjusted for the patient's clinical history using 8 indications, 16 past diagnoses, and 3 past procedures, it is possible that unobserved factors or residual confounding may account for some component of patient selection for robotic surgery. For example, we did not have information on the patient's severity of endometriosis, and although we adjusted for history (yes/no), we could not control for severity. If robotic patients were more complex and we underestimated complexity, the study would have understated the association of the robotic approach with operative time. In contrast, if robotic patients were less complex, the study would have overstated the association.
A cost analysis was outside the study's scope. Our health care system originally purchased the robotic surgical systems for treatment of prostate cancer and conditions other than benign uterine disease, so that the systems represented a sunk (nonrecoverable) cost. One recent analysis of costs using hysterectomy data from Brigham and Women's Hospital during 2009 observed significantly different operating room costs, with vaginal hysterectomy at $26,690; abdominal, $31,084; laparoscopic, $33,879; and robotic $43,794. 30 The mean total patient costs were $31,934 for vaginal, $38,312 for laparoscopic, $43,622 for abdominal, and $49,526 for robotic hysterectomy. 30 In 2015, the American College of Obstetricians and Gynecologists together with the Society of Gynecologic Surgeons issued an opinion concerning the role of robotic surgery in gynecology. 18 They identified the need for research to determine which patients are likely to benefit from robot-assisted surgery. Our study is helpful in identifying the level of benefit that can be provided to complex patients through use of a high-volume surgeon, the robotic approach, or both.
CONCLUSION
Results of this study suggest that for women with complex disease, the robotic approach to hysterectomy, when used by a higher-volume surgeon, may be associated with shorter operative time and slightly less blood loss, but is not associated with lower risk of complications. v a Available from: www.thepermanentejournal.org/files/2020/19-035suppl.pdf.
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